Literature DB >> 1468208

Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma.

D Moutsiakis1, P Mancuso, H Krutzsch, W Stetler-Stevenson, S Zucker.   

Abstract

In this study, we have identified and characterized metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs) in human plasma. Treatment of plasma with trypsin or aminophenylmercuric acetate resulted in activation of latent gelatinolytic activity. Fractionation of plasma by gelatin Sepharose chromatography resulted in the isolation of 72 kDa and 92 kDa gelatinases/type IV collagenases. The 72 kDa gelatinase was purified by gel filtration chromatography. Stromelysin-1 was isolated from plasma by Matrex green A affinity chromatography. Immunoblotting of plasma fractions with antibodies to unique peptide regions of human gelatinases differentiated the 72 kDa gelatinase from the 92 kDa gelatinase. Antibodies to the amino terminal peptides of each enzyme were used to determine that plasma gelatinases circulate as latent proenzymes. Immunoblotting with antibodies directed against human stromelysin identified a 57 kDa stromelysin. TIMP-1 (28 kDa) and TIMP-2 (21 kDa) were also identified by immunoblotting of gelatin Sepharose bound plasma proteins using non-crossreacting antibodies to each protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468208     DOI: 10.3109/03008209209015038

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  9 in total

1.  ProMMP-2: TIMP-1 complexes identified in plasma of healthy individuals.

Authors:  Stanley Zucker; Cathleen E Schmidt; Antoine Dufour; Robert C Kaplan; Hyun I Park; Weiping Jiang
Journal:  Connect Tissue Res       Date:  2009       Impact factor: 3.417

2.  Neutrophil activator of matrix metalloproteinase-2 (NAM).

Authors:  Ellen E Rollo; Michelle Hymowitz; Cathleen E Schmidt; Steve Montana; Hussein Foda; Stanley Zucker
Journal:  Clin Exp Metastasis       Date:  2006-11-04       Impact factor: 5.150

Review 3.  MMP induction and inhibition in myocardial infarction.

Authors:  Merry L Lindsey
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

4.  EMMPRIN-mediated MMP regulation in tumor and endothelial cells.

Authors:  Stéphanie Caudroy; Myriam Polette; Béatrice Nawrocki-Raby; Jian Cao; Bryan P Toole; Stanley Zucker; Philippe Birembaut
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.

Authors:  S Zucker; P Mancuso; B DiMassimo; R M Lysik; C Conner; C L Wu
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

6.  Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases.

Authors:  I Sopata; J Wize; A Filipowicz-Sosnowska; E Stanisławska-Biernat; B Brzezińska; S Maśliński
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

7.  Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9.

Authors:  Maria Pavlaki; Eleftheria Giannopoulou; Anna Niarakis; Panagiota Ravazoula; Alexios J Aletras
Journal:  Mol Cell Biochem       Date:  2009-03-29       Impact factor: 3.396

Review 8.  Matrix-degrading proteases in hormone-dependent breast cancer.

Authors:  R B Dickson; Y E Shi; M D Johnson
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.

Authors:  M N Holten-Andersen; G Murphy; H J Nielsen; A N Pedersen; I J Christensen; G Høyer-Hansen; N Brünner; R W Stephens
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.